Clinical Trial Update: Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic Syndromes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating azacitidine with lintuzumab in previously untreated myelodysplastic syndromes was terminated after results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Lintuzumab (lintuzumab)

Snippet

Sponsor: Alison Walker | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: TERMINATED | Results posted: 2013-11-26